RN7SL106P

Across TCGA pan-cancer cohorts, RN7SL106P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RN7SL106P data layer compared with 1 for mutation status.

The strongest signal is observed in brain lower grade glioma (LGG), where higher RN7SL106P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL106P expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

LGG, STAD, and LIHC are the cancer types where RN7SL106P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	OS	Tertile	All	0.204	0.810	<.001	36	view →
STAD	OS	Tertile	IV	0.805	0.283	.031	18	view →
LIHC	OS	Tertile	All	0.177	0.783	.003	18	view →
GBM	OS	Tertile	All	0.089	0.415	.037	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RN7SL106P–LGG (OS)

Open the LGG breakdown →